61 related articles for article (PubMed ID: 3156701)
21. Erythrocyte complement receptor type I in patients with hematologic diseases.
Yen JH; Liu HW; Lin SF; Chen TP
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Aug; 22(3):186-92. PubMed ID: 2532592
[TBL] [Abstract][Full Text] [Related]
22. Frequency of HLA antigens in chronic myelocytic leukemia.
Hester JP; Rossen R; Trujillo J; McCredie KB; Freireich EJ
South Med J; 1977 Jun; 70(6):691-3. PubMed ID: 69321
[TBL] [Abstract][Full Text] [Related]
23. C3b receptor (CR1) on erythrocytes and the HLA-DR3 antigen.
Malaise M; Desoroux A; Mahieu P; Franchimont P
Arthritis Rheum; 1986 Feb; 29(2):300-1. PubMed ID: 2937410
[No Abstract] [Full Text] [Related]
24. Human histocompatibility antigens and survival in acute myelocytic leukemia.
Markman M; Braine HG; Bias WB; Karp JE
Cancer; 1984 Apr; 53(7):1515-7. PubMed ID: 6582993
[TBL] [Abstract][Full Text] [Related]
25. Age at onset, sex distribution and HLA antigen frequency in patients with primary glomerulonephritis progressing to terminal uraemia. An epidemiological survey.
Forsberg B; Johnson U
Scand J Urol Nephrol; 1987; 21(4):301-6. PubMed ID: 3445128
[TBL] [Abstract][Full Text] [Related]
26. Study of HLA antigens among Japanese schizophrenics.
Asaka A; Okazaki Y; Namura I; Juji T; Miyamoto M; Ishikawa B
Br J Psychiatry; 1981 Jun; 138():498-500. PubMed ID: 7296179
[TBL] [Abstract][Full Text] [Related]
27. [Erythrocyte complement receptor (C3b) expression in multiple sclerosis].
Nowak J; Wender M
Neurol Neurochir Pol; 1990; 24(5-6):277-85. PubMed ID: 2131424
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR genotyping by restriction fragment length polymorphism analyses.
Hui K; Festenstein H; de Klein A; Grosveld G; Grosveld F
Immunogenetics; 1985; 22(3):231-9. PubMed ID: 2995247
[TBL] [Abstract][Full Text] [Related]
29. Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
Ruuska PE; Ikäheimo I; Silvennoinen-Kassinen S; Käär ML; Tiilikainen A
Clin Exp Immunol; 1992 Jul; 89(1):18-21. PubMed ID: 1352745
[TBL] [Abstract][Full Text] [Related]
30. Preliminary study of HLA-ABCDR antigens in CML, ANLL, thalassemia and severe aplastic anemia in Thais.
Chiewsilp P; Sujirachato K; Mongkolsuk T; Junpong S; Jootar S; Hathirat P
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S130-6. PubMed ID: 10865419
[TBL] [Abstract][Full Text] [Related]
31. Chronic myelocytic leukaemia: HLA association and decreased erythrocyte C3b receptor expression.
Ruuska P; Silvennoinen-Kassinen S; Timonen T; Tiilikainen A
Clin Exp Immunol; 1985 Feb; 59(2):300-4. PubMed ID: 3156701
[TBL] [Abstract][Full Text] [Related]
32. Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.
Ruuska P; Ilonen J; Mustonen A; Tiilikainen A
Clin Exp Immunol; 1984 Jul; 57(1):12-6. PubMed ID: 6235073
[TBL] [Abstract][Full Text] [Related]
33. [Association between HLA antigens and leukemia in the population of Vojvodina].
Vojvodić S; Belić B; Popović S
Med Pregl; 2001; 54(3-4):128-34. PubMed ID: 11759203
[TBL] [Abstract][Full Text] [Related]
34. HLA system affects the age-at-onset in chronic myeloid leukemia.
Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West Indies.
Cameron ES; Labastide WB; Wilson V; Charles W; Holder Y; Reid HF
Leukemia; 1990 Sep; 4(9):615-9. PubMed ID: 2395381
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
